A growing global health concern, Lyme disease has become the most common tick-borne disease in the United States and Europe. Caused by the bacterial spirochete Borrelia burgdorferi sensu lato (sl), this disease can be debilitating if not treated promptly. Because diagnosis is challenging, prevention remains a priority; however, a previously licensed vaccine is no longer available to the public. Here, we designed a six component vaccine that elicits antibody (Ab) responses against all Borrelia strains that commonly cause Lyme disease in humans. The outer surface protein A (OspA) of Borrelia was fused to a bacterial ferritin to generate self-assembling nanoparticles. OspA-ferritin nanoparticles elicited durable high titer Ab responses to the seven major serotypes in mice and non-human primates at titers higher than a previously licensed vaccine. This response was durable in rhesus macaques for more than 6 months. Vaccination with adjuvanted OspA-ferritin nanoparticles stimulated protective immunity from both B. burgdorferi and B. afzelii infection in a tick-fed murine challenge model. This multivalent Lyme vaccine offers the potential to limit the spread of Lyme disease.

Department of Molecular Biology and Microbiology Tufts University 136 Harrison Ave Boston MA 02111 USA

Institute of Parasitology Biology Centre of the Czech Academy of Sciences Ceske Budejovice Czech Republic

Sanofi 640 Memorial Dr Cambridge MA 01239 USA

Zobrazit více v PubMed

Rosa PA, Tilly K, Stewart PE. The burgeoning molecular genetics of the Lyme disease spirochaete. Nat. Rev. Microbiol. 2005;3:129–143. doi: 10.1038/nrmicro1086. PubMed DOI

Steere AC, et al. Lyme borreliosis. Nat. Rev. Dis. Prim. 2016;2:16090. doi: 10.1038/nrdp.2016.90. PubMed DOI PMC

Adrion ER, Aucott J, Lemke KW, Weiner JP. Health care costs, utilization and patterns of care following Lyme disease. PloS ONE. 2015;10:e0116767. doi: 10.1371/journal.pone.0116767. PubMed DOI PMC

Sykes RA, Makiello P. An estimate of Lyme borreliosis incidence in Western Europedagger. J. Public Health (Oxf.) 2017;39:74–81. PubMed

Wilking H, Stark K. Trends in surveillance data of human Lyme borreliosis from six federal states in eastern Germany, 2009-2012. Ticks Tick.-borne Dis. 2014;5:219–224. doi: 10.1016/j.ttbdis.2013.10.010. PubMed DOI

Waindok P, Schicht S, Fingerle V, Strube C. Lyme borreliae prevalence and genospecies distribution in ticks removed from humans. Ticks Tick.-borne Dis. 2017;8:709–714. doi: 10.1016/j.ttbdis.2017.05.003. PubMed DOI

Rizzoli, A. et al. Lyme borreliosis in Europe. Euro. Commun. Dis. Bull.16, 19906 (2011). PubMed

CDC. Signs and Symptoms of Untreated Lyme Disease, https://www.cdc.gov/lyme/signs_symptoms/index.html (2020).

Marques AR. Laboratory diagnosis of Lyme disease: advances and challenges. Infect. Dis. Clin. North Am. 2015;29:295–307. doi: 10.1016/j.idc.2015.02.005. PubMed DOI PMC

Marques A. Chronic Lyme disease: a review. Infect. Dis. Clin. North Am. 2008;22(341–360):vii–viii. PubMed PMC

de Silva AM, Telford SR, 3rd, Brunet LR, Barthold SW, Fikrig E. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J. Exp. Med. 1996;183:271–275. doi: 10.1084/jem.183.1.271. PubMed DOI PMC

Steere AC, et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N. Engl. J. Med. 1998;339:209–215. doi: 10.1056/NEJM199807233390401. PubMed DOI

Willett TA, Meyer AL, Brown EL, Huber BT. An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope. Proc. Natl Acad. Sci. USA. 2004;101:1303–1308. doi: 10.1073/pnas.0305680101. PubMed DOI PMC

Livey I, et al. A new approach to a Lyme disease vaccine. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2011;52(Suppl 3):s266–270. doi: 10.1093/cid/ciq118. PubMed DOI

Comstedt P, Schuler W, Meinke A, Lundberg U. The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes. PloS ONE. 2017;12:e0184357. doi: 10.1371/journal.pone.0184357. PubMed DOI PMC

del Rio B, et al. Oral immunization with recombinant lactobacillus plantarum induces a protective immune response in mice with Lyme disease. Clin. Vaccin. immunology: CVI. 2008;15:1429–1435. doi: 10.1128/CVI.00169-08. PubMed DOI PMC

Cho KJ, et al. The crystal structure of ferritin from Helicobacter pylori reveals unusual conformational changes for iron uptake. J. Mol. Biol. 2009;390:83–98. doi: 10.1016/j.jmb.2009.04.078. PubMed DOI

Kanekiyo M, et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature. 2013;499:102–106. doi: 10.1038/nature12202. PubMed DOI PMC

Kanekiyo M, et al. Rational design of an Epstein-Barr virus vaccine targeting the receptor-binding site. Cell. 2015;162:1090–1100. doi: 10.1016/j.cell.2015.07.043. PubMed DOI PMC

Georgiev IS, et al. Two-component ferritin nanoparticles for multimerization of diverse trimeric antigens. ACS Infect. Dis. 2018;4:788–796. doi: 10.1021/acsinfecdis.7b00192. PubMed DOI PMC

Kitahara R, et al. A delicate interplay of structure, dynamics, and thermodynamics for function: a high pressure NMR study of outer surface protein A. Biophys. J. 2012;102:916–926. doi: 10.1016/j.bpj.2011.12.010. PubMed DOI PMC

Trikha J, Theil EC, Allewell NM. High resolution crystal structures of amphibian red-cell L ferritin: potential roles for structural plasticity and solvation in function. J. Mol. Biol. 1995;248:949–967. doi: 10.1006/jmbi.1995.0274. PubMed DOI

Koide S, Yang X, Huang X, Dunn JJ, Luft BJ. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA. J. Mol. Biol. 2005;350:290–299. doi: 10.1016/j.jmb.2005.04.066. PubMed DOI

Sears JE, et al. Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of Lyme disease. J. Immunol. 1991;147:1995–2000. PubMed

Wilske B, et al. Molecular analysis of the outer surface protein A (OspA) of Borrelia burgdorferi for conserved and variable antibody binding domains. Med. Microbiol. Immunol. 1992;181:191–207. doi: 10.1007/BF00215765. PubMed DOI

Jiang W, Gorevic PD, Dattwyler RJ, Dunn JJ, Luft BJ. Purification of Borrelia burgdorferi outer surface protein A (OspA) and analysis of antibody binding domains. Clin. diagnostic Lab. Immunol. 1994;1:406–412. doi: 10.1128/CDLI.1.4.406-412.1994. PubMed DOI PMC

Jiang W, Bonnert TP, Venugopal K, Gould EA. A single chain antibody fragment expressed in bacteria neutralizes tick-borne flaviviruses. Virology. 1994;200:21–28. doi: 10.1006/viro.1994.1158. PubMed DOI

Gross DM, et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science. 1998;281:703–706. doi: 10.1126/science.281.5377.703. PubMed DOI

Steere AC, Drouin EE, Glickstein LJ. Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2011;52(Suppl 3):s259–26. doi: 10.1093/cid/ciq117. PubMed DOI PMC

Scheckelhoff MR, Telford SR, Hu LT. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs. Vaccine. 2006;24:1949–1957. doi: 10.1016/j.vaccine.2005.10.044. PubMed DOI PMC

Golde WT, et al. Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi. Infect. Immun. 1997;65:882–889. doi: 10.1128/IAI.65.3.882-889.1997. PubMed DOI PMC

Vesikari T, Pepin S, Kusters I, Hoffenbach A, Denis M. Assessment of squalene adjuvanted and non-adjuvanted vaccines against pandemic H1N1 influenza in children 6 months to 17 years of age. Hum. vaccines immunotherapeutics. 2012;8:1283–1292-. doi: 10.4161/hv.21265. PubMed DOI PMC

O’Hagan DT, Ott GS, De Gregorio E, Seubert A. The mechanism of action of MF59—an innately attractive adjuvant formulation. Vaccine. 2012;30:4341–4348. doi: 10.1016/j.vaccine.2011.09.061. PubMed DOI

Yassine HM, et al. Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection. Nat. Med. 2015;21:1065–1070. doi: 10.1038/nm.3927. PubMed DOI

Lynn, G. M. et al. In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity. Nat. Biotechnol. 33, 1201–1210 (2015). PubMed PMC

Bockenstedt LK, Fikrig E, Barthold SW, Kantor FS, Flavell RA. Inability of truncated recombinant Osp A proteins to elicit protective immunity to Borrelia burgdorferi in mice. J. Immunol. 1993;151:900–906. PubMed

Johnson BJ, et al. Incomplete protection of hamsters vaccinated with unlipidated OspA from Borrelia burgdorferi infection is associated with low levels of antibody to an epitope defined by mAb LA-2. Vaccine. 1995;13:1086–1094. doi: 10.1016/0264-410X(95)00035-Y. PubMed DOI

Schwendinger MG, et al. Evaluation of OspA vaccination-induced serological correlates of protection against Lyme borreliosis in a mouse model. PloS ONE. 2013;8:e79022. doi: 10.1371/journal.pone.0079022. PubMed DOI PMC

Fikrig E, Barthold SW, Kantor FS, Flavell RA. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science. 1990;250:553–556. doi: 10.1126/science.2237407. PubMed DOI

Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene. 1989;77:61–68. doi: 10.1016/0378-1119(89)90359-4. PubMed DOI

Lander GC, et al. Appion: an integrated, database-driven pipeline to facilitate EM image processing. J. Struct. Biol. 2009;166:95–102. doi: 10.1016/j.jsb.2009.01.002. PubMed DOI PMC

Sorzano CO, et al. XMIPP: a new generation of an open-source image processing package for electron microscopy. J. Struct. Biol. 2004;148:194–204. doi: 10.1016/j.jsb.2004.06.006. PubMed DOI

Stepanova-Tresova G, Kopecky J, Kuthejlova M. Identification of Borrelia burgdorferi sensu stricto, Borrelia garinii and Borrelia afzelii in Ixodes ricinus ticks from southern Bohemia using monoclonal antibodies. Zentralblatt fur Bakteriologie Int. J. Med. Microbiol. 2000;289:797–806. doi: 10.1016/S0934-8840(00)80005-5. PubMed DOI

Pospisilova, T. et al. Tracking of Borrelia afzelii transmission from infected Ixodes ricinus Nymphs to Mice. Infect. Immunity10.1128/IAI.00896-18 (2019). PubMed PMC

Fipronil prevents transmission of Lyme disease spirochetes

Pathogenicity and virulence of Borrelia burgdorferi

Lyme disease transmission by severely impaired ticks

Identification of Tick Ixodes ricinus Midgut Genes Differentially Expressed During the Transmission of Borrelia afzelii Spirochetes Using a Transcriptomic Approach